Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy

S. Lucioli, B. Giusti, E. Mercuri, O. Camacho Vanegas, L. Lucarini, V. Pietroni, A. Urtizberea, R. Ben Yaou, M. De Visser, A. J. Van Der Kooi, C. Bönnemann, S. T. Iannaccone, L. Merlini, K. Bushby, F. Muntoni, E. Bertini, M. L. Chu, Guglielmina Pepe

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Background: Dominant mutations in COL6A1, COL6A2, and COL6A3, the three genes encoding collagen type VI, a ubiquitous extracellular matrix protein, are associated with Bethlem myopathy (BM) and Ullrich scleroatonic muscular dystrophy. Methods: The authors devised a method to screen the entire coding sequence of the three genes by reverse transcriptase-PCR amplification of total RNA from skin fibroblasts and direct sequencing of the resulting 25 overlapping cDNA fragments covering 107 exons. Results: Four splicing and four missense mutations were identified in 16 patients with BM, six of which are novel mutations in COL6A1. Both common and private mutations are localized in the α1 (VI) chain between the regions corresponding to the 3′ end of the NH2-globular domain and the 5′ end of the triple helix, encoded by exons 3 through 14. Conclusions: The clustering of the mutations in a relatively narrow area of the three collagen type VI chains in patients with Bethlem myopathy (BM) suggests that mutations in different regions could result in different phenotypes or in no phenotype at all. Moreover, the detection of mutations in only 60% of the patients suggests the existence of at least another gene associated with BM. The authors propose the direct sequencing of COL6 cDNAs as the first mutation screening analysis in BM, given the high number of exon-skipping events.

Original languageEnglish (US)
Pages (from-to)1931-1937
Number of pages7
JournalNeurology
Volume64
Issue number11
DOIs
StatePublished - Jun 14 2005

Fingerprint

Mutation
Genes
Collagen Type VI
Exons
Complementary DNA
Phenotype
Extracellular Matrix Proteins
Missense Mutation
Bethlem myopathy
Reverse Transcriptase Polymerase Chain Reaction
Cluster Analysis
Fibroblasts
RNA
Skin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lucioli, S., Giusti, B., Mercuri, E., Vanegas, O. C., Lucarini, L., Pietroni, V., ... Pepe, G. (2005). Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Neurology, 64(11), 1931-1937. https://doi.org/10.1212/01.WNL.0000163990.00057.66

Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. / Lucioli, S.; Giusti, B.; Mercuri, E.; Vanegas, O. Camacho; Lucarini, L.; Pietroni, V.; Urtizberea, A.; Yaou, R. Ben; De Visser, M.; Van Der Kooi, A. J.; Bönnemann, C.; Iannaccone, S. T.; Merlini, L.; Bushby, K.; Muntoni, F.; Bertini, E.; Chu, M. L.; Pepe, Guglielmina.

In: Neurology, Vol. 64, No. 11, 14.06.2005, p. 1931-1937.

Research output: Contribution to journalArticle

Lucioli, S, Giusti, B, Mercuri, E, Vanegas, OC, Lucarini, L, Pietroni, V, Urtizberea, A, Yaou, RB, De Visser, M, Van Der Kooi, AJ, Bönnemann, C, Iannaccone, ST, Merlini, L, Bushby, K, Muntoni, F, Bertini, E, Chu, ML & Pepe, G 2005, 'Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy', Neurology, vol. 64, no. 11, pp. 1931-1937. https://doi.org/10.1212/01.WNL.0000163990.00057.66
Lucioli S, Giusti B, Mercuri E, Vanegas OC, Lucarini L, Pietroni V et al. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Neurology. 2005 Jun 14;64(11):1931-1937. https://doi.org/10.1212/01.WNL.0000163990.00057.66
Lucioli, S. ; Giusti, B. ; Mercuri, E. ; Vanegas, O. Camacho ; Lucarini, L. ; Pietroni, V. ; Urtizberea, A. ; Yaou, R. Ben ; De Visser, M. ; Van Der Kooi, A. J. ; Bönnemann, C. ; Iannaccone, S. T. ; Merlini, L. ; Bushby, K. ; Muntoni, F. ; Bertini, E. ; Chu, M. L. ; Pepe, Guglielmina. / Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. In: Neurology. 2005 ; Vol. 64, No. 11. pp. 1931-1937.
@article{980c83e8bf494ab1ba6d3bed121de649,
title = "Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy",
abstract = "Background: Dominant mutations in COL6A1, COL6A2, and COL6A3, the three genes encoding collagen type VI, a ubiquitous extracellular matrix protein, are associated with Bethlem myopathy (BM) and Ullrich scleroatonic muscular dystrophy. Methods: The authors devised a method to screen the entire coding sequence of the three genes by reverse transcriptase-PCR amplification of total RNA from skin fibroblasts and direct sequencing of the resulting 25 overlapping cDNA fragments covering 107 exons. Results: Four splicing and four missense mutations were identified in 16 patients with BM, six of which are novel mutations in COL6A1. Both common and private mutations are localized in the α1 (VI) chain between the regions corresponding to the 3′ end of the NH2-globular domain and the 5′ end of the triple helix, encoded by exons 3 through 14. Conclusions: The clustering of the mutations in a relatively narrow area of the three collagen type VI chains in patients with Bethlem myopathy (BM) suggests that mutations in different regions could result in different phenotypes or in no phenotype at all. Moreover, the detection of mutations in only 60{\%} of the patients suggests the existence of at least another gene associated with BM. The authors propose the direct sequencing of COL6 cDNAs as the first mutation screening analysis in BM, given the high number of exon-skipping events.",
author = "S. Lucioli and B. Giusti and E. Mercuri and Vanegas, {O. Camacho} and L. Lucarini and V. Pietroni and A. Urtizberea and Yaou, {R. Ben} and {De Visser}, M. and {Van Der Kooi}, {A. J.} and C. B{\"o}nnemann and Iannaccone, {S. T.} and L. Merlini and K. Bushby and F. Muntoni and E. Bertini and Chu, {M. L.} and Guglielmina Pepe",
year = "2005",
month = "6",
day = "14",
doi = "10.1212/01.WNL.0000163990.00057.66",
language = "English (US)",
volume = "64",
pages = "1931--1937",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy

AU - Lucioli, S.

AU - Giusti, B.

AU - Mercuri, E.

AU - Vanegas, O. Camacho

AU - Lucarini, L.

AU - Pietroni, V.

AU - Urtizberea, A.

AU - Yaou, R. Ben

AU - De Visser, M.

AU - Van Der Kooi, A. J.

AU - Bönnemann, C.

AU - Iannaccone, S. T.

AU - Merlini, L.

AU - Bushby, K.

AU - Muntoni, F.

AU - Bertini, E.

AU - Chu, M. L.

AU - Pepe, Guglielmina

PY - 2005/6/14

Y1 - 2005/6/14

N2 - Background: Dominant mutations in COL6A1, COL6A2, and COL6A3, the three genes encoding collagen type VI, a ubiquitous extracellular matrix protein, are associated with Bethlem myopathy (BM) and Ullrich scleroatonic muscular dystrophy. Methods: The authors devised a method to screen the entire coding sequence of the three genes by reverse transcriptase-PCR amplification of total RNA from skin fibroblasts and direct sequencing of the resulting 25 overlapping cDNA fragments covering 107 exons. Results: Four splicing and four missense mutations were identified in 16 patients with BM, six of which are novel mutations in COL6A1. Both common and private mutations are localized in the α1 (VI) chain between the regions corresponding to the 3′ end of the NH2-globular domain and the 5′ end of the triple helix, encoded by exons 3 through 14. Conclusions: The clustering of the mutations in a relatively narrow area of the three collagen type VI chains in patients with Bethlem myopathy (BM) suggests that mutations in different regions could result in different phenotypes or in no phenotype at all. Moreover, the detection of mutations in only 60% of the patients suggests the existence of at least another gene associated with BM. The authors propose the direct sequencing of COL6 cDNAs as the first mutation screening analysis in BM, given the high number of exon-skipping events.

AB - Background: Dominant mutations in COL6A1, COL6A2, and COL6A3, the three genes encoding collagen type VI, a ubiquitous extracellular matrix protein, are associated with Bethlem myopathy (BM) and Ullrich scleroatonic muscular dystrophy. Methods: The authors devised a method to screen the entire coding sequence of the three genes by reverse transcriptase-PCR amplification of total RNA from skin fibroblasts and direct sequencing of the resulting 25 overlapping cDNA fragments covering 107 exons. Results: Four splicing and four missense mutations were identified in 16 patients with BM, six of which are novel mutations in COL6A1. Both common and private mutations are localized in the α1 (VI) chain between the regions corresponding to the 3′ end of the NH2-globular domain and the 5′ end of the triple helix, encoded by exons 3 through 14. Conclusions: The clustering of the mutations in a relatively narrow area of the three collagen type VI chains in patients with Bethlem myopathy (BM) suggests that mutations in different regions could result in different phenotypes or in no phenotype at all. Moreover, the detection of mutations in only 60% of the patients suggests the existence of at least another gene associated with BM. The authors propose the direct sequencing of COL6 cDNAs as the first mutation screening analysis in BM, given the high number of exon-skipping events.

UR - http://www.scopus.com/inward/record.url?scp=20444396862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444396862&partnerID=8YFLogxK

U2 - 10.1212/01.WNL.0000163990.00057.66

DO - 10.1212/01.WNL.0000163990.00057.66

M3 - Article

C2 - 15955946

AN - SCOPUS:20444396862

VL - 64

SP - 1931

EP - 1937

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -